Gossamer Bio
GOSS
#9904
Rank
โ‚ฌ73.06 M
Marketcap
0,15ย โ‚ฌ
Share price
-3.03%
Change (1 day)
-90.00%
Change (1 year)

Revenue for Gossamer Bio (GOSS)

Revenue in 2026 (TTM): โ‚ฌ47.47 Million

According to Gossamer Bio's latest financial reports the company's current revenue (TTM ) is โ‚ฌ48.08 Million. In 2025 the company made a revenue of โ‚ฌ41.26 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Gossamer Bio from 2018 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ47.47 M15.05%
2025 โ‚ฌ41.26 M-62.57%
2024 โ‚ฌ0.11 B
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA